As Chief Executive Officer, Troy provides strategic leadership and operational oversight across Veramed’s global business. He works closely with the Executive Leadership Team and Board to drive innovation, growth, and long-term value for clients and employees.

Troy brings over 20 years of experience in the life sciences sector, having held senior leadership roles at mid to large-sized CROs. His background spans operational delivery, business development, and executive management, with a strong focus on building high-performing, people-first cultures.

Troy holds a PhD in Pharmaceutical Sciences and a BS in Chemistry. He is based in North Carolina, USA.

As Co-Founder and EVP, Data, AI and Innovation, Matthew’s responsibilities include the provision of strategic technical direction and enablement for the company.

Matthew began his pharmaceutical career in clinical programming, and over the past 25 years he has sought ways to accelerate drug development through the right combination of people, process and technology. This inspired Matthew to found Veramed in 2012, perform the role of CEO for the first 13 years of the company’s evolution, and ultimately to move into his current role.

Matthew holds a BSc in Economics from the University of Nottingham (1999) and an MBA from Cranfield University (2006).

Emma is responsible for enabling the Veramed Biostatistics team to achieve the highest levels of quality from consultancy to reporting. Emma continues to provide statistical consultancy to clients to maintain her statistical acumen.

Emma has a wealth of experience in vendor oversight, statistical consultancy and of clinical statistical analysis gained from a variety of leading global pharmaceutical companies. She has knowledge in both technical and non-technical aspects of study design and statistical analysis across clinical studies from Phase I-III and multiple therapeutic areas, including oncology, respiratory and immunology.

Emma holds a PhD in Statistics and is an active member of Statisticians in Pharmaceutical Industry (PSI). Emma was the Conference Chair for the 2015 and 2016 annual conference in London and Berlin, respectively.

Tom has over ten years’ experience in HR, six of which have been in the tech/education space, building his previous organisation through two private sales for scale and subsequently, integration. As Veramed’s Chief People Officer, he’s responsible for driving People strategy and optimising processes to help Veramed continue to scale, build, maintain and develop an exceptional team.

Tom’s passion is implementing people strategies aligned with our Executive Leadership Team’s strategic vision. He works to conserve our people-focused culture, while optimising important functions such as recruitment, training, professional development, performance management, and remuneration.

Tom holds an MSc in Human Resource Management from Cardiff University and is a Chartered Member of the CIPD (Chartered Institute of Personnel and Development).

As Chief Financial Officer, Dan’s responsibilities include the provision of strategic direction and operational leadership of the companies financial management and commercial support function. Dan has held a number of senior financial leadership positions, having most recently spent 10 years as the CFO for a Global Marketing Outsourcing agency which he led the MBO of in 2014 and eventual exit to PE. Prior to that, he worked for Avon cosmetics in a number of senior Finance positions with 11 years being spent working international in Europe, APAC and North America.

Dan holds a BA (Hons) in Accountancy as well as being a Fellow Chartered Management Accountants (FCMA).

Karen Curran is a Chief Strategic Officer at Veramed. She has 25+ years in the Biopharma Industry with Clinical Research Organizations, leading global teams across Standards & Innovation, Data Management, Statistics, Statistical Programming and Medical Writing. With a proven ability to successfully develop, manage and grow dynamic global business units, Karen also has market Expertise in providing strategic guidance and developing innovative solutions for biometric processes, including CDISC adoption and implementation, on both large and small pharma and CRO environments.

Karen has extensive CDISC management knowledge and submission experience including the FDA, EMEA and the PMDA alongside an active leadership involvement in the PHUSE organisation for 5+ years and being a member of the CDISC Board of Directors.

Prior to Veramed, Karen held roles as the Vice President, Global Strategic Partnerships at IQVIA, Vice President and General Manager at CSG, and the Vice President of Global Strategic Partnerships at Covance. Karen received her BS in Mathematics from Shippensburg University, and her MBA from Penn State University.

Stuart is responsible for leading the development of the business as it evolves its position as the pharmaceutical industry’s preferred statistics and programming CRO partner.

Stuart has over 20 years of Pharmaceutical experience having first started work in anti-malaria research which took him to Moshi, Tanzania. He then moved to the Clinical Research Organisation Chiltern (latterly Covance) where he took on Business Development, Leadership and Alliance Partnership roles delivering significant growth over 19 years. Stuart has a wide platform of relationships in the pharmaceutical and biotech industry, covering Europe, North America and Japan.

Stuart holds a BSc in Chemistry from the University of Surrey (1999) and recently received his level III wine diploma from the Wines and Spirits Education Trust.

Katherine has 35 years of experience within the pharmaceutical industry, in large and small pharma, as well as 20+ years in the service sector. Her statistical career has spanned all phases of drug development through supporting regulatory submissions, post-submission registries and observational studies.

In her managerial career, Katherine has gained an in-depth knowledge of operational and client account management, supporting and developing staff in their careers, whilst maintaining a focus on client needs.

Katherine has an MSc in Applied Statistics (1994, Sheffield Hallam University) and a BSc in Mathematics (1986, Leeds University). As an active member of Statisticians in Pharmaceutical Industry (PSI), Katherine has held positions on their Board of Directors, including Chair (2011-2012)

Daniil is an experienced Programmer who has climbed the ranks in the industry and now leads global teams. With over 14 years of experience in clinical SAS programming, he has collaborated with CROs and major Pharmaceutical companies throughout his career. He also works training newcomers to the industry and participates in university programs as a mentor.

As Ukraine Country Leader, Daniil has oversight of all Line Managers in Ukraine and supports the Veramed Executive Leadership and Operational Teams in strategic management of Veramed Ukraine, providing input into recruitment, process improvement, legal consultation, finance management, and day-to-day operations.

Gaurab has close to 19 years of experience in Biostatistics and Statistical Programming, with a bachelor's degree in Statistics and a master's in Computer Applications. He started his career as an intern at the National Informatics Centre, switching to the pharmaceutical sector in 2006 when he joined GSK. He joined Fortrea (legacy Omnicare) in March 2010, overseeing biometrics statistical programming in India. Under his leadership, the team blossomed and grew 15 times in size. Alongside his work commitments, he is involved with ISCR and CDISC, and has presented at various industry forums. Currently, he is the chair of ISCR's Biostatistics council. As Head of Veramed India, Gaurab has overall strategic and operational responsibility, overseeing staff, programs, and mission execution in the region.